Sanofi India · NSE: SANOFI · BSE: 500674

Q4 FY24 results · Jan–Mar 2024

Sanofi India reported revenue from operations of ₹732.40 crore and net profit of ₹136.60 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY24	Q4 FY23	YoY	Q3 FY24	QoQ
Revenue from operations	732.40	—	—	693.90	+5.5%
Other income	6.50	—	—	12.00	−45.8%
Total income	738.90	—	—	705.90	+4.7%
Profit before tax	188.40	—	—	188.80	−0.2%
Net profit for the period	136.60	—	—	137.70	−0.8%
EPS, basic (₹)	59.31	—	—	59.79	−0.8%
Net margin (%)	18.7	—		19.8

Standalone · ₹ crore
Item	Q4 FY24	Q4 FY23	YoY	Q3 FY24	QoQ
Revenue from operations	732.40	736.50	−0.6%	693.90	+5.5%
Other income	6.50	25.80	−74.8%	12.00	−45.8%
Total income	738.90	762.30	−3.1%	705.90	+4.7%
Profit before tax	188.40	263.50	−28.5%	188.80	−0.2%
Net profit for the period	136.60	190.40	−28.3%	137.70	−0.8%
EPS, basic (₹)	59.31	82.67	−28.3%	59.79	−0.8%
Net margin (%)	18.7	25.9		19.8

Consolidated

Standalone